How to implement blinding within in vivo research?
Dr. Natasha Karp
Associate Director for Biostatistics, Astra Zeneca
sowie
Randomization and Blinding – Insights from a preclinical multi-center, confirmatory drug trial
Dr. Lars Björn Riecken
Scientific Lab Manager, Leibniz Institute on Aging, Jena